Terms: = Endocrine gland cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Prognosis
8 results:
1. Total thyroidectomy versus unilateral lobectomy for unilateral multifocal papillary thyroid carcinoma: systematic review and meta‑analysis.
Chen H; Liu Y; Huang D; Zhang X; She L
Updates Surg; 2024 Jan; 76(1):33-41. PubMed ID: 38127193
[TBL] [Abstract] [Full Text] [Related]
2. [Testicular tumours from a clinical point of view : What urologists and oncologists need to know from the pathologist about testicular cancer].
Oing C; Fankhauser CD
Pathologie (Heidelb); 2022 Nov; 43(6):434-440. PubMed ID: 36156132
[TBL] [Abstract] [Full Text] [Related]
3. Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.
Liu HJ; Qin Y; Zhao ZH; Zhang Y; Yang JH; Zhai DH; Cui F; Luo C; Lu MX; Liu PP; Xu HW; Li K; Sun B; Chen S; Zhou HG; Yang C; Sun T
Theranostics; 2020; 10(20):9083-9099. PubMed ID: 32802180
[No Abstract] [Full Text] [Related]
4. Challenges and controversies in the conservative management of uterine and ovarian cancer.
Janda M; McGrath S; Obermair A
Best Pract Res Clin Obstet Gynaecol; 2019 Feb; 55():93-108. PubMed ID: 30243603
[TBL] [Abstract] [Full Text] [Related]
5. Expression and significance of ARID1A mRNA in endometriosis- associated ovarian cancer.
Wang Q; Wang L; L Y; Ding X; Liu A
J BUON; 2017; 22(5):1314-1321. PubMed ID: 29135119
[TBL] [Abstract] [Full Text] [Related]
6. Folate Receptor Alpha Expression in Platinum Resistant/Refractory Ovarian Carcinomas and Primary Endocervical Adenocarcinomas.
Rubinsak LA; Cohen C; Khanna N; Horowitz IR; Hanley KZ
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):567-572. PubMed ID: 27941566
[TBL] [Abstract] [Full Text] [Related]
7. Management of well-differentiated thyroglossal remnant thyroid carcinoma: time to close the debate? Report of five new cases and proposal of a definitive algorithm for treatment.
Plaza CP; López ME; Carrasco CE; Meseguer LM; Perucho Ade L
Ann Surg Oncol; 2006 May; 13(5):745-52. PubMed ID: 16538412
[TBL] [Abstract] [Full Text] [Related]
8. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.
Berchuck A; Kamel A; Whitaker R; Kerns B; Olt G; Kinney R; Soper JT; Dodge R; Clarke-Pearson DL; Marks P
Cancer Res; 1990 Jul; 50(13):4087-91. PubMed ID: 1972347
[TBL] [Abstract] [Full Text] [Related]
